Since LPS was discovered, all inquiry in the field was motivated by two articles of faith. First, it was held that LPS was an important factor in microbial pathogenesis. Second, it was held that the responses elicited by numerous molecules of microbial origin might be formally similar to the responses elicited by LPS. The identification of TLR4 as the core transducer of LPS responses, and the added discovery that other TLR paralogs sense other microbial products, has strongly validated these cherished beliefs. Moreover, it has amalgamated many separate lines of inquiry, and focused attention on the how the innate immune system perceives infection.
SEPSIS: THE 'CAUSE OF THE CAUSE'
A mysterious phenomenon is seldom explained all at once. Incremental investigations reveal the proximal cause of the phenomenon; then the cause of the cause is sought; then the cause of the cause of the cause, and so on, until a point of profound understanding is reached. Such has been the history of research in the sepsis field, now nearly 300 years old, though to be sure, there were some leaps and milestones along the way.
In antiquity, physicians surely observed that severe infection was associated with systemic toxicity, akin to poisoning. Even to this day, the term 'blood poisoning' is used in common parlance to denote sepsis of almost any cause. The imperative was this: to understand the nature of the poisoning and how it occurs. Why does local infection sicken and kill the host? What accounts for action at a distance? We now consider the problem in molecular terms, but it was not always possible to do so, particularly in the pre-microbial era, when rot and decay were not linked to microbes so reflexively as they are now, and molecules themselves were but an abstraction.
As reviewed by Rietschel and Westphal, 1 systematic examination of the problem of sepsis during the 18th century led to the realization that putrescent organic material is indeed poisonous to mammals and other vertebrates; then, in the 19th century, to the discovery that microbes within infected tissue are the primary source of the poison concerned. Later, chemical methods were used to separate the molecular constituents of microbes that were poisonous. Of these there were many: bacterial lipopeptides; lipoteichoic acid, DNA, and foremost for our present understanding of sepsis, endotoxin -first so named by Pfeiffer 2 -later known as lipopolysaccharide (LPS). The story of LPS and its chemical characterization by Pfeiffer, his contemporaries, and his successors has been elegantly set forth in a two-part review by Rietschel and Cavaillon. 3, 4 By the mid 20th century, LPS stood as the premiere exponent of Gram-negative pathogenesis. Undoubtedly, its stability, abundance, and potency contributed to its assignment as such. Administered to animals, it could do what bacteria themselves do: cause fever, shock, coagulopathy, and metabolic disturbances, leading to a lethal effect if sufficient amounts were administered. As a result, LPS had been studied in great detail.
From exhaustive and painstaking chemical analysis, it was known that the molecule had a toxic lipid A moiety, and a relatively non-toxic polysaccharide moiety. [5] [6] [7] [8] [9] The complete structure of the Salmonella typhimurium lipid A was determined in 1983, 10 and in turn, a bacterial lipid A molecule was artificially synthesized, and shown to be toxic in 1984. 11 The mechanism of LPS toxicity -equivalent to the mechanism of LPS sensing -remained an open question, however, and an exceptionally important one, for two reasons. First, most Gram-negative organisms produced LPS, and understanding how it exerted its untoward biological effects would surely be helpful to the understanding of Gram-negative pathogenesis. It might even be that specific therapeutic measures would grow from such understanding. Second, LPS was not unique in its actions, and solving the problem of mechanism for LPS was likely to shed light on the mode of action of many pathogen-derived molecules that caused the septic syndrome -perhaps all of them. It might be judged that Gram-positive bacteria, which produce no LPS, create a septic syndrome indistinguishable from that of LPS itself. Hence, many microbial molecules appeared to trigger similar effects in the mammalian host, perhaps acting synergistically ( Fig. 1 ). How did they do so?
LPS SIGNALING

LPS signals through only one receptor: the cardinal lesson of the C3H/HeJ mouse
The genetic approach to LPS pathogenesis had its roots in the discovery that mice of the C3H/HeJ strain are utterly resistant to LPS. 12 This resistance was not observed in closely related C3H substrains, and was, from the start, presumed to reflect the fixation of a spontaneous mutation in the C3H/HeJ line. The mice were not partially resistant, as would be expected if there were multiple independent receptor/transducer systems responsible for LPS action. Rather, if truly pure LPS was administered to these animals, they were indifferent to it.
The so-called Lps locus was defined by this spontaneous mutation. The locus was mapped to the distal third of mouse chromosome 4, to a position between the Mup-1 and Ps loci, in 1978. An allelic defect was identified in a second, unrelated strain of mice some years later. 13, 14 Again, two closely related strains were identified, one LPS responsive (C57BL/10ScSn) and the other resistant (C57BL/10ScCr). Hence, chance had provided the means to discover an essential component of the LPS signaling pathway: in the end, the component that would be most informative with respect to microbial signaling in general. But the tools with which to exploit this mutation were still fairly remote, and would become accessible only three decades later.
In the meanwhile, it was shown that LPS works its Fig. 1 . Microbial cells are distinguished from host cells in many ways; some subtle and some obvious. Lipid A (upper left), the toxic center of LPS, is represented in almost all Gram-negative bacteria, a schematic example of which is presented at the lower right. Both Gram-negative and Gram-positive cells have peptidoglycan, a complex polymer (upper center) that is adorned with lipopeptides, and also contains D-amino acids and diaminopimelic acid, substructures not found in vertebrates. These are shown as pentameric 'beads' attached to the backbone. M, methionine; G, glycine. Bacterial DNA is unmethylated at CpG dinucleotide residues, whereas vertebrate DNA is methylated at these sites. Each of these structural landmarks is recognized by a specific mammalian Toll-like receptor.
lethal effect via interaction with hematopoietically derived cells, 15 and, more specifically, through interaction with macrophages. 16, 17 The soluble mediators produced by macrophages are legion, and these mediators represent the endogenous toxins responsible for the morbid effects of LPS. Among these, TNF was one of the first to be identified and, early on, TNF was shown to be the cytokine most important in LPS pathogenesis, insofar as neutralization of TNF nearly tripled the lethal dose of LPS. 18 To date, no other cytokine has been shown to make a contribution of this magnitude.
Biochemical studies of LPS signaling
The identification of TNF as a biologically relevant endpoint of LPS-induced macrophage activation marked the beginning of a new era in LPS research. Henceforth, attention could be directed toward the elucidation of the signals elicited by LPS in those cells that exhibited the most relevant response to it. Foremost in importance would be the earliest signaling events, wherein chemical recognition of LPS, presumably by a specific receptor, took place. The fact that mutations at the Lps locus could abolish LPS signaling suggested that such a constriction in the signaling pathway must exist. As already noted, the identification of the LPS receptor was to be accorded high priority, since many microbial determinants provoked responses similar to those provoked by LPS. Either a number of paralogous proteins likely subserved signaling, or else, a mechanism for receptor diversification must assure that innate immune cells, like their adaptive immune counterparts, could signal via a common pathway. Some investigators began to search for the earliest signaling events in a retrograde fashion, beginning at the level of the TNF promoter, and examining the factors that led to enhancement of TNF gene transcription. In this context, NF-! B quickly emerged as a crucial protein, 19 and subsequent efforts were made to follow the signal upstream toward its source. The MAPK (ERK) cascade, 20 as well as the p38 paralog of MAPK, 21 were found to be activated by LPS, as was the JUNK (SAPK) cascade, 22, 23 and the PI3K cascade. 24 Many studies made use of specific inhibitors to block signaling and, as such, the involvement of tyrosine kinases was suspected as well. But in the end, the critical, apical events that led to signal transduction were not be found by retrograde, biochemical analysis.
A major leap forward occurred with the identification of CD14 as a concentrating receptor for LPS on the surface of macrophages. 25 The importance of CD14 in LPS signaling was validated by gene knockout work, in which a lack of CD14 greatly increased resistance to the lethal effect of LPS in mice. 26 But as CD14 was bereft of a cytoplasmic domain, it could not signal by itself, and the identity of the transmembrane signaling protein that surely must exist remained elusive.
GENETICS
The cloning of Lps, the gene encoding the central binding and signaling component of the LPS receptor complex
The primacy of a forward genetic (i.e. phenotype-driven) approach to the assignment of gene function is well illustrated by the cloning of Lps, since conflicting conclusions about the nature of the LPS receptor arose from contemporaneous work that relied upon softer methods. Forward genetics entails positional cloning and, in positional cloning, an effort is made to confine a phenotypic effect (in this case, the failure of LPS-treated macrophages to produce TNF) to a discrete genomic interval by demonstrating meiotic recombination between limiting markers that are found along the chromosome and the mutation that confers the effect. When such a confinement has been made, the mutation can inexorably be found by examining every gene within the interval, and demonstrating a unique genetic difference between mutant and control strains.
Over a period spanning 5 years, the Lps locus was cloned positionally by Poltorak et al., who reported their observations in 1998. 27, 28 Mice of the C3H/HeJ and C57BL/10ScCr strains were found to have mutations at the Tlr4 locus: in the first instance, a point mutation that changed an invariant proline residue to a histidine within the cytoplasmic domain of the membrane-spanning Toll-like receptor 4 protein (P712H); and, in the second instance, deletion of the entire coding region of the locus. Subsequently, a second mutation was identified in C57BL/10ScCr mice which causes premature truncation of the IL-12R} 2 protein, creating an independent immune defect. 29 This mutation accounts for several phenotypic differences between C3H/HeJ and C57BL/10ScCr mice. [30] [31] [32] Two days after the initial genetic confinement of the Lps locus to a region including Tlr4 was announced, together with the explicit suggestion that TLR4 was the product of the Lps, 27 other workers reported that TLR2, rather than TLR4, was the LPS receptor. 33 This view was echoed in a second study, performed by an independent group and published 2 months later. 34 In both of these reports, over-expression of TLR2 was shown to confer sensitivity to very high concentrations of LPS in 293 cell cultures, whereas TLR4 over-expression conferred no sensitivity to LPS. Moreover, LPS could purportedly bind to TLR2 in a specific manner. 33 The notion that two independent signaling pathways might serve LPS recognition was inconsistent with the unassailable fact that a single mutation -in C3H/HeJ or C57BL/10ScCr mice -could entirely ablate LPS signaling. Hence, the solitary nature of the LPS signaling pathway had been taken as a fact for many years. While the notion that TLR2 might be a part of the LPS receptor might once have been entertained, no data supporting this model had been advanced, and all chance of such a situation was removed when the TLR2 gene was destroyed by knockout without any effect on LPS signaling. 35 On the other hand, the essential role of TLR4 in LPS signaling was later confirmed by targeted deletion of the gene, 36 which produced a phenocopy of the natural mutations identified through positional cloning.
TLRS
The TLRs, and the ultimate validation of LPS as a model in microbial pathogenesis
TLR4, essential component of the one and only LPS sensor of mammals, is one of 10 paralogous proteins encoded in the human genome. These proteins are now known to sense distinct, conserved molecules of microbial origin, and to do so with a degree of specificity that is, in some cases, very narrow; in other cases, rather broad. TLR2, for example, acts to sense lipoteichoic acid (LTA), peptidoglycan, and certain bacterial lipopeptides -rather disparate structures. 35 TLR5 is believed to sense flagellin, a bacterial protein represented in both Grampositive and Gram-negative organisms. 37 TLR9 is able to recognize unmethylated CpG dinucleotides in microbial DNA, 38 provided that they reside in the correct sequence context. 39 The signals that emanate from these different receptors are rather similar, though quantitatively distinct, since all of the TLRs are served by a common transducer protein, MyD88. This likely accounts for the clinical similarity of Gram-negative, Gram-positive, and fungal sepsis, though it must be noted that some proteins, such as MAL/Tirap, 40, 41 are specific in their interaction with TLR4, and some qualitative difference in signaling undoubtedly exist. Hence, at the genomic level, some transcription units are likely to answer to LPS, but not to lipopeptides, and vice versa. MyD88-dependent and -independent signals have been observed in MyD88knockout mice. 42 Notably, B-cell mitogenesis and the overall lethal effect of LPS are essentially abolished by MyD88 knockout; however, LPS signals to the level of NF-! B and MAPK activation in macrophages that lack MyD88, occurring with somewhat different kinetics than are observed in normal cells. This is but one indication that more components of the activation pathway remain to be discovered.
The overarching fact that a single class of proteins acts as to sense diverse microbial products is immensely satisfying, from the standpoint that LPS research was, for approximately 100 years, impelled by two blind faith arguments. First, it was believed that LPS was relevant to the toxicity of microbes, rather than an in vitro curiosity that played little role during an authentic infection. Second, implicit in the study of LPS was the belief that it stood as a model for most of the invariant toxins produced by microbes. In other words, it was hoped that what was learned about LPS sensing would ultimately shed light on microbial sensing in general. This now appears to have been the case.
Proof of direct interaction between TLR4 and its ligand, LPS
Toll, the namesake of the TLR family of proteins, was shown in 1996 to have a dual function in Drosophila. It directs the establishment of dorsoventral polarity in the fly embryo; 43 but, when activated in the adult, stimulates the expression of genes encoding antimicrobial peptides. 44 Hence, Toll, one of nine Drosophila paralogs, confers awareness of infection just as the TLRs do in mammals. However, it is clear that Toll does not interact directly with molecules of microbial origin. Rather, it interacts with Spätzle, a protein ligand cleaved to assume an active form in response to signals initiated by pathogen molecules that have yet to be identified. Spätzle is activated by a proteolytic cascade and, while the components of this cascade are not known, at least one inhibitor of the cascade, a serpin encoded by the Necrotic (Nec) gene of Drosophila, has been identified, and mutations of Nec lead to constitutive activation of the Toll pathway. 45 Moreover, at least two proximal receptors for microbial products, one of them a protein in the hemolymph of the adult fly, 46 and one of them a membrane-bound protein that interacts with a non-Toll sensing pathway, 47, 48 have been identified.
The fact of interaction between LPS and TLR4 has best been demonstrated by genetic complementation work, predicated on the observation that certain lipid A partial structures are bereft of stimulatory activity when applied to human cells, while still active on mouse cells. For example, tetra-acyl lipid A, which lacks the secondary acyl chains of intact lipid A, is species specific in this manner. The species origin of TLR4 has been shown to determine whether or not a response to tetra-acyl lipid A will occur. 49, 50 This observation provides very strong and direct evidence of physical interaction between TLR4 and LPS, insofar as TLR4 is capable of making a 'decision' as to whether secondary acyl chains are present. A similar line of reasoning supports the concept of direct interaction between microbial DNA and TLR9. 39 
STRUCTURE
The complete structure of the LPS receptor complex Gene targeting or the induction of germline mutations by other means must ultimately be used to establish the importance of a protein within the sensing apparatus of an innate immune cell. CD14 is known to be important for LPS sensing because gene knockout work has proved it to be so. The story of the essential function of TLR4 itself has already been told. MD-2, a small protein believed to associate with the TLR4 ectodomain, is purportedly also required for LPS signaling. 51 It has been reported that a mutation within the MD-2 protein is associated with LPS resistance in CHO cells. On the cytoplasmic side of the receptor complex, MyD88 is known to be very important for LPS signaling; 42 the importance of MAL/Tirap awaits confirmation. Very recent work has revealed that an isozyme of IRAK, known as IRAK-4, is crucially important as a transducer of the LPS signal. 52 It should be stressed at this point that not all components of the LPS receptor complex are necessarily known. Indeed, there is reason to think that some proteins may have escaped detection. Such 'missing' elements of the complex may best be found by the use of germline mutations as a primary tool. This might take the form of candidate analysis, using gene targeting to create knockout mutations. But when candidates are in short supply (as is presently the case), a random, saturation mutagenesis strategy may be more effective.
FORWARD GENETIC ANALYSIS
The concept of the 'phenotype gap' holds that there are presently far more genes than phenotypes, from which fact it may be inferred that the essential function of most genes remains to be discovered. 53 There are two different (and largely complementary) methods for determining the function of mammalian genes, thereby closing the phenotype gap. These methods are gene targeting and saturation mutagenesis.
Gene targeting is a 'reverse genetic' method. One proceeds from the gene to the phenotype. Starting with a gene of unknown function, one destroys it selectively and then studies the phenotypic effect. Saturation mutagenesis is a more classical, 'forward genetic' approach to the decipherment of gene function. It is used to produce phenotypes that, in turn, can be traced to defects in specific genes. In the present instance, the phenotype of interest would be failure of LPS sensing, and both methods have been used to study it already.
Reverse genetic methods are, at their best, driven by hypothesis: that is to say, by intuition concerning function. Otherwise, there is no motivation to undertake the knockout of a gene. Moreover, one must be relatively accurate in one's judgment about what a gene will do; otherwise, no phenotype will be readily apparent, or a nondescript lethal phenotype may be the outcome. Gene targeting is a relatively economical approach to the assignment of function, provided that it is successful at achieving this end. It is also faster than saturation mutagenesis if the hypothesis that drives gene knockout is correct. However, it cannot readily be used to find all of the genes that are required for a given function, however, since knockouts must be made and examined one at a time, and there are about 34,000 genes in the mammalian genome. While it often yields surprising insights, these insights most often lie outside the bounds of what the investigator meant to study in the first place.
Forward genetic methods are, by contrast, discovery driven. They are best applied when there is no clear molecular claimant to a particular function, or when the investigator wishes to find all of the genes that subserve a given function. But to undertake a deep saturation screen, the question must necessarily be an important one, lest the expense of the undertaking be unjustified. In mice, the method of choice for introducing germline mutations is N-ethyl-N-nitrosourea (ENU), a powerful alkylating agent that creates A^T and A^G substitutions at random across the genome. The rate of mutagenesis is such that each mouse born to an ENU-treated parent may have in excess of 100 amino acid substitutions across the proteome. Deep saturation of the genome may be achieved by examining a few thousand mice in a dominant screen, or a few tens of thousands of mice in a recessive screen.
The mutations created by ENU may: (i) be phenotypically neutral; (ii) destroy the function of proteins that are modified by them; or (iii) may create intermediate effects. From this standpoint, ENU mutagenesis offers a certain advantage over gene knockout in the assignment of function, in that null alleles are intentionally generated using gene knockout in the first instance, and some null alleles do not reveal the complete spectrum of functions carried out by the gene of interest. But the greatest advantage of ENU lies in the fact that it is an unbiased method for the discovery of genes that serve a particular function. Neither guesswork nor intuition has any place in the strategy of ENU mutagenesis; rather, the investigator sets his sights upon a phenotype of interest and accepts what is given to him.
Long applied to lower organisms, mutagenesis is now regarded by many as the most effective tool with which to examine complex immune phenomena. Its appeal derives partly from the fact that positional cloning, once to be regarded as the most difficult aspect of a forward genetic approach, has been greatly simplified by the recent acquisition and annotation of mouse and human genome sequences. Hence, mapping alone is sufficient to permit the investigator to find a mutation. It is no longer necessary to clone all of the genomic DNA across a critical region, nor to seek candidates within that region: at least in principle, all candidates are known, and all are immediately available for examination by sequencing.
THE FUTURE
The promise held by LPS lay in its ability to mimic sepsis. LPS was a siren that sang: 'understand how I signal and you will understand how all microbes harm the host'.
LPS has, in the end, shown us a tremendous amount. It has revealed the principal sensors of the mammalian innate immune system. It has led us to understand the ultimate cause of sepsis. When sepsis occurs, we may now be quite certain that it involves signaling through a minute quantity of receptor protein. In an animal the size of a mouse, LPS delivers its lethal effect through interaction with macrophages alone, and at that, though interaction with a very low-abundance protein expressed by macrophages. Perhaps 1-10 ng of TLR4 light the fire of endotoxic shock. If the other TLRs are expressed at similar concentrations, the story is no less amazing, and the opportunity for highly selective blockade of signaling (if that is what is desired) could hardly be more perfect.
At the same time, not all components of the signaling apparatus are yet clear to us, nor is our understanding of the complex downstream events in sepsis anywhere near resolution. In the past, biochemical and immunological methods were used to grapple with complex biological problems. While these tools still have a clear place in the approach to sepsis, strong genetic methods -both forward and reverse -will likely reveal many of the proteins that are central to the aberrant events that transpire.
